
Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials
Murray, P I, Bristow, E, Forsythe, B J, Faulkner, K, Tullo, A B, Esmaeli, BVolume:
19
Année:
2005
Langue:
english
Pages:
10
DOI:
10.1038/sj.eye.6701630
Fichier:
PDF, 187 KB
english, 2005